AQST Cash & Equivalents
Aquestive Therapeutics Inc · Cash & Equivalents
AQST Cash & Equivalents
Latest reported$121.17Mperiod ending
AQST FY Cash & Equivalents ($9.21M → $121.17M)
Annual Cash & Equivalents
High-resolution chart · PNG
AQST cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 121,169,000 | |
| 71,546,000 | |
| 23,872,000 | |
| 27,273,000 | |
| 28,024,000 | |
| 31,807,000 | |
| 49,326,000 | |
| 60,599,000 | |
| 17,379,000 | |
| 9,209,000 |